[化疗对广泛性浆细胞瘤患者生存率及其毒性的各种危害的影响] - Suppr | 超能文献

[Effect of chemotherapy on the survival of patients with generalized plasmacytoma and various hazards of its toxicity].

作者信息

Sakalová A, Hrubisko M, Gazová S, Steruská M, Prümmerová J, Oravská D, Pokorná G, Mayer J

出版信息

Vnitr Lek. 1979 May;25(5):425-35.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Effect of chemotherapy on the survival of patients with generalized plasmacytoma and various hazards of its toxicity].[化疗对广泛性浆细胞瘤患者生存率及其毒性的各种危害的影响]

Vnitr Lek. 1979 May;25(5):425-35.

2

[Duration of disease and survival time in plasmacytoma].[浆细胞瘤的病程及生存时间]

Z Gesamte Inn Med. 1970 Dec 1;25(23):1071-4.

3

[Clinical trial with long-term therapy of generalized plasmacytoma].[多发性骨髓瘤长期治疗的临床试验]

Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(1):57-63.

4

Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松辅助化疗与单药左旋苯丙氨酸氮芥治疗可手术乳腺癌且腋窝淋巴结阳性患者的比较：西南肿瘤协作组20年研究结果

Cancer. 2003 Jan 1;97(1):21-9. doi: 10.1002/cncr.10982.

5

[Results of plasmacytoma therapy].[浆细胞瘤治疗结果]

Hamatol Bluttransfus. 1976;18:395-400.

6

Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model.在小鼠浆细胞瘤模型中对泼尼松、阿霉素、硫唑嘌呤和长春新碱组成的骨髓瘤维持方案的评估。

Cancer Clin Trials. 1981;4(2):135-41.

7

[Cytostatic treatment of plasmacytoma].[浆细胞瘤的细胞抑制治疗]

Z Gesamte Inn Med. 1972 Nov 1;27(21):933-7.

8

Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.采用环磷酰胺、表柔比星、长春新碱和泼尼松联合治疗的中或高级别非霍奇金淋巴瘤患者的长期随访

Cancer. 2004 Jan 15;100(2):350-5. doi: 10.1002/cncr.11907.

9

[A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].[美罗华（利妥昔单抗）治疗对标准化疗耐药的惰性非霍奇金淋巴瘤的三年经验]

Vopr Onkol. 2004;50(4):421-5.

10

Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.环磷酰胺、长春新碱、阿霉素和强的松联合方案（CHOP）可提高缓解率，但不能延长生存期，且与米托蒽醌、苯丁酸氮芥和强的松联合方案（MCP）相比，在滤泡性和套细胞淋巴瘤中血液学毒性更低：德国低度淋巴瘤研究组一项前瞻性随机试验的结果

Cancer. 2006 Sep 1;107(5):1014-22. doi: 10.1002/cncr.22093.